Effective January 2018, most regions around the globe will be adopting new regulations that limit direct commercial funding to physicians for travel to any medical conferences. The Medical Device Industry has formed regulatory agencies, Ethical MedTech in Europe and APACMED in Asia to implement these regulations. Other regions, including Latin America are adopting similar regulations. The reduction of direct commercial support will have a huge impact on medical meetings and their international attendance. It is anticipated that the Pharmaceutical Industry will likely follow suit by 2019, if not before.
- Understand the details of these new regulations and what’s driving the Medical Device Industry to put them in place.
- Learn how to adhere to both international and ACCME regulations for commercial support that apply to CME Providers.
- Identify and discuss potential solutions to preserve international physician attendance at your medical meeting.
How Will the EFPIA Disclosure Code Change Medical Meetings?
How Will Europe’s New MedTech Guidelines Affect Your Meetings?
1 Clock Hour
Domain A: Strategic Planning
James Youngblood began his career in training and organization development positions, understanding how organizations work and how to structure them for optimal work environments and high performance.
Most of his career has been spent in health care association management. He held several senior level positions at the American Heart Association and currently serves as CEO of the Heart Rhythm Society, the global education and advocacy organization for professionals in the field of heart rhythm disorders.
Christina Wurster is HRS’s Chief Revenue Officer. As a member of the executive leadership’s Strategic Advisory Group, she oversees Global Strategic Partnerships, the Business Development Team and Publications. She has served HRS in many capacities, including most recently as Vice President of the Brand Team. She has over 15 years of experience in strategic marketing, communications and corporate relations. Prior to joining HRS in 2009, she held marketing management positions at Massachusetts General Hospital in Boston, MA and GlaxoSmithKline.
She holds a BA in business administration and communications from Indiana University and an MBA from the University of Massachusetts-Boston, where she participated in exchange programs at Villanova University and Tsinghua University in China. She is currently an Associate Adjunct Professor at University of Maryland’s University College, where she teaches marketing, sales and healthcare management.